Novo Nordisk is planning to slash the price of several insulin drugs by up to 75% in the U.S., following a similar move by Eli Lilly.
Billionaire investor Ken Griffin’s flagship hedge fund matched the broader market’s performance in the beginning of 2023 following a record year.
Southwest is sending its operating chief, but not its CEO, to the Senate Commerce committee hearing.
Tesla CEO Elon Musk was found not liable in a shareholder class-action suit stemming from 2018 tweets in which he said he was considering taking Tesla private.
Shares of Snap tumbled after the company released disappointing earnings for the third quarter in a row.
The amount companies have pledged to support racial justice has grown to nearly $340 billion, according to McKinsey & Company senior partner Shelley Stewart.
The attempt to create a new license comes as Hasbro’s Wizards of the Coast unit looks to capitalize on a surge in Dungeons & Dragons’ popularity.
Markets closed out the week — and the year — in the red, as the so-called Santa Claus rally failed to materialize.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}